CD274 and small cell lung carcinoma: Consequently, in our opinion, the metabolic profiling of SCLC patients deserves further investigations and validation, particularly in relation with newly emerging prognostic/predictive variable (PD-L1 expression on tumor cells and peripheral T cells, genomic/transcriptomic signatures and classifications).